RCM Technologies, Inc. (RCMT) Market Cap
RCM Technologies, Inc. has a market capitalization of $234.3M.
Financials based on reported quarter end 2026-01-03
Price: $31.62
▲ 0.55 (1.77%)
Market Cap: 234.32M
NASDAQ · time unavailable
CEO: Bradley S. Vizi
Sector: Industrials
Industry: Conglomerates
IPO Date: 1983-09-12
Website: https://www.rcmt.com
RCM Technologies, Inc. (RCMT) - Company Information
Market Cap: 234.32M · Sector: Industrials
RCM Technologies, Inc. provides business and technology solutions in the United States, Canada, Puerto Rico, and Serbia. It operates through three segments: Engineering, Specialty Health Care, and Life Sciences and Information Technology. The Engineering segment offers a range of engineering services, including project management engineering and design, engineering analysis, engineer-procure-construct, configuration management, hardware/software validation and verification, quality assurance, technical writing and publications, manufacturing process planning and improvement, and 3D/BIM integrated design. The Specialty Health Care segment provides long-term and short-term staffing, executive search, and placement services in the fields of allied and therapy staffing, correctional healthcare staffing, health information management, nursing services, physician and advanced practice, school services, and telepractice. The Life Sciences and Information Technology segment provides enterprise business solutions, application services, infrastructure solutions, competitive advantage, life sciences solutions, and other vertical market specific solutions. The company serves aerospace and defense, energy, financial services, health care, life sciences, manufacturing and distribution, and technology industries, as well as educational institutions and the public sector. RCM Technologies, Inc. was founded in 1971 and is based in Pennsauken, New Jersey.
Analyst Sentiment
Based on 3 ratings
Consensus Price Target
No data available
Price & Moving Averages
Related Companies in Industrials
PERMA FIX ENVIRONMENTAL SERVICES I (PESI)
Industrials
$0.23B
Mkt Cap
OUTDOOR HOLDING (POWW)
Industrials
$0.24B
Mkt Cap
AIRJOULE TECHNOLOGIES CORP CLASS A (AIRJ)
Industrials
$0.22B
Mkt Cap
ALTA EQUIPMENT GROUP INC CLASS A (ALTG)
Industrials
$0.22B
Mkt Cap
GENCOR INDUSTRIES INC (GENC)
Industrials
$0.21B
Mkt Cap
AIRO GROUP HOLDINGS INC (AIRO)
Industrials
$0.26B
Mkt Cap
Fundamentals Overview
Management presented Q4 and 2026 as stronger (record 2026 engineering backlog; expected highest Q4 gross profit and adjusted EBITDA), and the tone is confident on growth drivers: healthcare penetration, Energy Services execution, and Life Sciences AI/compliance initiatives. However, the Q&A reveals near-term operational pressure points. Cash flow was “disappointing” in Q3 due to administrative collection issues with two large school clients. Healthcare is also carrying a heavy medical-claims overhang—$0.8M over budget in Q3 and $1.8M year-to-date—described as hard to forecast and driven by inflationary hospital/insurance cost pressures. Seasonal forecasting also missed on summer-session demand. Foreign nurse hiring is promising (300+ passed exams; potential 50–60 added if visa dates shift by a few months), but timing is explicitly dependent on visa retrogression—analysts pressed for order-of-magnitude impact and got uncertainty. Energy Services is confident but “don’t get too far over your skis” signals discipline amid active market opportunities.
Growth Catalysts
- Record 2026 engineering backlog (end of October) and increased traction with existing healthcare clients
- Energy Services: record backlog for 2026 and momentum in integrated engineering + EPC for grid hardening/modernization
- Aerospace & Defense: momentum in existing programs and awards such as Bell Flight Best New Supplier (2025)
- Life Sciences: AI-driven computer software validation/equipment qualification partnership to streamline compliance and reduce turnaround times
- Healthcare: increased penetration with existing K-12 school clients and pipeline for 300+ foreign-trained nurses ready to deploy pending visa timing
Business Development
- Healthcare: expanding roster of new school partners and broadened commitments from existing school clients (K-12 staffing)
- Life Sciences: partnering with an AI-driven computer software validation and equipment qualification company (named not provided)
- Energy Services: deepening strategic partnerships with OEMs to improve procurement agility and mitigate equipment lead time constraints
- Aerospace & Defense: Bell Flight recognized RCMT as Best New Supplier in 2025
Financial Highlights
- Q3 consolidated gross profit: $19.4M (+8.8% YoY)
- Q3 adjusted EBITDA: $5.5M vs $5.6M prior year (down 1.4%)
- Q3 adjusted EPS: $0.42 (flat vs Q3 2024)
- Healthcare Q3 gross profit: $9.0M vs $8.3M (+8.5%) but gross margin down to 30.0% vs 31.2%
- Healthcare Q3 revenue: school revenue $24.4M vs $20.2M (+20.7%); non-school revenue $5.6M vs $6.4M (-11.3%)
- Engineering Q3 gross profit: $6.9M vs $5.9M (+17.3%) but gross margin down to 22.0% vs 24.4%
- IT/Life Sciences/Data Solutions Q3 gross profit: $3.5M vs $3.7M (-4.2%); gross margin up to 39.5% vs 38.0%
- Medical claims headwind: SG&A included $0.8M costs over budget in Q3 alone and $1.8M year-to-date
- Cash flow: CFO said they were disappointed with Q3 cash flow from operations due to administrative collection issues with 2 large school clients
- Guidance tone: management expects Q4 to deliver highest quarterly gross profit and highest adjusted EBITDA in fiscal 2025
Capital Funding
- No explicit buyback dollar amount stated in this transcript
- Revolver in place; management states it provides ample capacity/financial flexibility
- Capital allocation context: management referenced prior share repurchases totaling 45% of outstanding shares (current outstanding ~7.4M shares) and average cost ~ $8.50 per share; ability to delever quickly
Strategy & Ops
- Healthcare seasonality issue in Q3: softer June/July/August due to fewer students in summer session and unpredictability year-to-year; Q3 recovered in September
- Medical cost mitigation: long-term measures to reduce medical claims costs; also discussed self-insured strategy
- Self-insured vs fully insured: company is self-insured (800+ covered lives); management said switching fully insured would be worse at their size
- Energy Services execution: hybrid resourcing model (domestic + global engineering design centers) and use of 3D BIM/digitalization
- Engineering mix/gross margin explanation: gross margin variability driven by revenue mix and amount of work performed by subs vs salaried employees; Aerospace lower margin; Industrial Processing randomness due to fixed direct-cost base
- Life Sciences operating emphasis: dedicated life sciences engineering group and integration of AI-driven compliance; scaling managed service offering
Market Outlook
- Energy Services backlog: Q3 update stated 2026 backlog just over $70M vs $21M backlog for 2025 at the same time last year
- Q4 expectations: highest quarterly gross profit and highest adjusted EBITDA in fiscal 2025
- Foreign nurse pipeline timing: CFO expects visa retrogression dates could move in Q4; even with a 3–4 month shift, could bring over 50–60 nurses; 300+ nurses already passed exams and are in the pipeline
Risks & Headwinds
- Healthcare medical costs: excess medical costs ~ $1.8M year-to-date with Q3 particularly hard; insurance premiums up significantly in 2025 vs 2024; medical claims difficult to forecast
- Cash flow risk: administrative collection issues with 2 large school clients caused disappointing operating cash flow in Q3
- Foreign recruitment execution risk: impact depends on visa retrogression; timing uncertain (management could not predict timing reliably)
- Healthcare seasonality/revenue risk: July/August revenue lower than expected due to fewer students taking summer session and less staffing need than forecast
- Industrial Process unit underperformance risk: strategy/personnel changes underway; unit is stable and small and unlikely to move needle, but management acknowledged it 'needs to be on a different trajectory'
- Engineering margins headwind: YoY gross margin down in engineering and Healthcare (mix effects and sub vs salaried work; Aerospace/Industrial Processing randomness)
Sentiment: MIXED
Note: This summary was synthesized by AI from the RCMT Q3 2025 earnings transcript. Financial data is complex; please verify all metrics against official SEC filings before making investment decisions.